Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/18/2003US20030175752 Comprises nucleotide sequences coding apyrase and/or hydrolase (NDPase) activity for treating or preventing thrombosis; thrombolytic agents
09/18/2003US20030175748 Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune- and colon- related tissues
09/18/2003US20030175746 Using oligonucleotide primers complimentary to virulence determinant genes (VDG) for classifying, identifying and diagnosing campylobacter infection
09/18/2003US20030175745 Peptides with growth inhibitory action
09/18/2003US20030175744 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175733 Polypeptides having diagnostic, preventive, therapeutic, and other uses
09/18/2003US20030175727 Peptide nucleic acid probe for detection of yeast
09/18/2003US20030175725 Mycobacterial diagnostics
09/18/2003US20030175715 Compositions and methods relating to breast specific genes and proteins
09/18/2003US20030175712 Comprises nucleic acid coding cell division cycle molecule (CDC24); g-protein coupled receptor for treatment and prevention of fungal infections; antitumor agents
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175710 Haplotypes of the TNFRSF11B gene
09/18/2003US20030175708 Nucleic acids and proteins from cenarchaeum symbiosum
09/18/2003US20030175707 Comprises nucleotide sequences coding prostate specific antigens for identifying, diagnosing, monitoring, staging, imaging and treating prostate cancer and non-cancerous disease in prostate tissue; drug screening; gene therapy
09/18/2003US20030175700 Comprises nucleotide sequences coding chlamydia antigen for serodiagnosis and traetment of infection; genetic vaccines
09/18/2003US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/18/2003US20030175685 Using amino acid sequences to control apoptosis and prevent or treat cancer and viral infections
09/18/2003US20030175681 Inhibition of CMV infection and dissemination
09/18/2003US20030175312 Novel mutant allergens
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175310 A pure immunogenic polypeptide for producing polyclonal and monoclonal antibodies
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175303 Production method of recombinant rotavirus structural proteins and vaccine composition
09/18/2003US20030175301 Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids
09/18/2003US20030175300 Cytotoxic Epstein-Barr virus T- cell epitopes are oligopeptides; vaccines
09/18/2003US20030175297 Cancer vaccines
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175294 Heterologous fusion protein constructs comprising a Leishmania antigen
09/18/2003US20030175293 Choline binding proteins for anti-pneumococcal vaccines
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175291 Multiple and multivalent DNA vaccines in ovo
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175288 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology
09/18/2003US20030175287 Fusion proteins comprising Pathogen Associated Molecular Patterns (PAMPs), immunostimulants and antigen or immunogens, administered to activate lymphocytes; immunology
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175279 Diagnosing and prophylaxis of tumors, endometriosis and fibroids, by administering Endometrial Steroid Binding Protein II (ESBPII) antagonists, then analyzing the polypeptide concentration in cells, tissues or fluids
09/18/2003US20030175278 Ubiquilin, a presenilin interactor and methods of using same
09/18/2003US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents
09/18/2003US20030175275 Methods of treatment by multiple administration of chimeric anti-TNF antibodies
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens
09/18/2003US20030175266 Peptides having amino acid sequences or fragments from human proteins, used as antitumor, anticarcinogenic and/or antiproliferative agents
09/18/2003US20030175265 Chandra: a novel Th1-specific gene
09/18/2003US20030175260 Novel DNA and a process for its use
09/18/2003US20030175252 Therapeutic compounds for ovarian cancer
09/18/2003US20030175250 Isolated peptides which bind to HLA molecules and uses thereof
09/18/2003US20030175246 Toxin-phage bacteriocide antibiotic and uses thereof
09/18/2003US20030175244 Capsid-modified recombinant adenovirus and methods of use
09/18/2003US20030175243 Blocking receptor binding; gene therapy; gastrin releasing peptide
09/18/2003US20030175239 Protein crystals are encapsulated within a matrix of a biocompatible polymeric carrier; enhance preservation of the native biologically active tertiary structure of the protein, creates reservoir for slow release of protein when needed
09/18/2003US20030175238 Chemokine conjugates
09/18/2003US20030175208 Treating a cancer of the immune system
09/18/2003US20030175207 A chelated complex comprised of lantibiotics and a transition or lanthanide metal, for a chemiluminescent assay of bacteria or fungi; binding to grampositive or mycobacterial cells or gramnegative bacteria
09/18/2003US20030173513 Probe for mass spectrometry
09/18/2003DE20121877U1 Module for suppressing leukocyte activity, useful e.g. in association with heart-lung machines, comprises a carrier linked to a ligand specific for the leukocyte receptor
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2518248A1 Proteolysis-resistant active vegf
09/18/2003CA2480962A1 Immunogenicity of glucan binding protein
09/18/2003CA2480910A1 Arrestin gene, polypeptide and methods of use thereof
09/18/2003CA2479056A1 Protein sustaining undifferentiated stem cells as such
09/18/2003CA2479021A1 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
09/18/2003CA2478846A1 Use of mixtures of lipopeptides for vaccine production
09/18/2003CA2478631A1 Method of inducing an enhanced immune response against hiv
09/18/2003CA2478604A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478593A1 Cancer-linked gene as target for chemotherapy
09/18/2003CA2478522A1 Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis
09/18/2003CA2478413A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2478371A1 Compositions and methods for generating an immune response
09/18/2003CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003CA2478271A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/18/2003CA2478224A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/18/2003CA2478177A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003CA2478126A1 Novel method for the production of hybrid maize seeds
09/18/2003CA2478104A1 Quantitative trait loci and somatostatin
09/18/2003CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/18/2003CA2478029A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003CA2477975A1 Novel vip3 toxins and methods of use
09/18/2003CA2477780A1 Methods of enhancing immune induction involving mda-7
09/18/2003CA2477675A1 Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein
09/18/2003CA2477577A1 Interferon beta-like molecules for treatment of stroke
09/18/2003CA2477273A1 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
09/18/2003CA2476767A1 Use of the mal protein as a tumour marker
09/18/2003CA2449341A1 Novel proteins and nucleic acids encoding same
09/17/2003EP1344829A1 Paramyxovirus vector encoding angiogenesis gene and use thereof
09/17/2003EP1344827A2 Antifreeze proteins from basidiomycetes
09/17/2003EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins
09/17/2003EP1344825A1 Fohy030 test kits
09/17/2003EP1344824A1 Mutated gene coding for a LAT protein and the biological applications thereof
09/17/2003EP1344823A1 Novel g protein-coupled receptor proteins and dnas thereof
09/17/2003EP1344536A1 Method of regulating the activity of expression product of gene transferred into living body
09/17/2003EP1344530A1 Interleukin-18 inducing agent
09/17/2003EP1344066A2 Protein s functional assay
09/17/2003EP1344064A2 Compositions and methods relating to prostate specific genes and proteins
09/17/2003EP1343904A2 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof
09/17/2003EP1343901A2 Novel human kinase interacting protein and polynucleotides encoding the same
09/17/2003EP1343897A2 Purified active hcv ns2/3 protease
09/17/2003EP1343896A1 Small acid-soluble spore protein and uses thereof
1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 2916